Is NLSPW or EQR a better dividend investment in 2026?

NLSPW currently yields 11173.18% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: NLSPW offers higher current income.

What is the dividend yield difference between NLSPW and EQR?

NLSPW has a forward dividend yield of 11173.18% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 11167.31 percentage points.

Home › Compare › NLSPW vs EQR

NLSPW vs EQR: Dividend Comparison 2026

NLSPW yields 11173.18% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NLSPW wins by $164653833954869728.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NLSPW

● Live price

11173.18%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$164653833954869728.00M

Annual income

$161,805,092,740,060,000,000,000.00

Full NLSPW calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — NLSPW vs EQR

📍 NLSPW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NLSPW	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NLSPW + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NLSPW pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NLSPW

Annual income on $10K today (after 15% tax)

$949,720.67/yr

After 10yr DRIP, annual income (after tax)

$137,534,328,829,050,980,000,000.00/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, NLSPW beats the other by $137,534,328,829,050,980,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NLSPW + EQR for your $10,000?

NLSPW: 50%EQR: 50%

100% EQR50/50100% NLSPW

Portfolio after 10yr

$82326916977434864.00M

Annual income

$80,902,546,370,030,000,000,000.00/yr

Blended yield

98.27%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

NLSPW

No analyst data

Altman Z

-30.8

Piotroski

3/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NLSPW buys

EQR buys

No recent congressional trades found for NLSPW or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNLSPWEQR

Forward yield	11173.18% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$164653833954869728.00M ✓	$47.8K
Annual income after 10y	$161,805,092,740,060,000,000,000.00 ✓	$5,475.61
Total dividends collected	$164464607760728672.00M ✓	$23.0K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: NLSPW vs EQR ($10,000, DRIP)

Year	NLSPW Portfolio	NLSPW Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$1,128,018	$1,117,318.44	$11,380	$679.82	+$1.12M → NLSPW
2	$118,997,241	$117,790,261.13	$13,014	$837.25	+$118.98M → NLSPW
3	$11,740,377,185	$11,613,050,136.92	$14,961	$1,036.20	+$11740.36M → NLSPW
4	$1,083,360,524,226	$1,070,798,320,638.87	$17,297	$1,289.22	+$1083360.51M → NLSPW
5	$93,504,509,375,855	$92,345,313,614,932.45	$20,121	$1,613.15	+$93504509.36M → NLSPW
6	$7,548,923,892,561,273	$7,448,874,067,529,108.00	$23,561	$2,030.84	+$7548923892.54M → NLSPW
7	$570,107,151,245,586,050	$562,029,802,680,545,500.00	$27,783	$2,573.54	+$570107151245.56M → NLSPW
8	$40,278,627,085,882,840,000	$39,668,612,434,050,070,000.00	$33,013	$3,284.39	+$40278627085882.81M → NLSPW
9	$2,662,374,967,111,925,000,000	$2,619,276,836,130,030,400,000.00	$39,547	$4,223.51	+$2662374967111925.00M → NLSPW
10	$164,653,833,954,869,740,000,000	$161,805,092,740,060,000,000,000.00	$47,791	$5,475.61	+$164653833954869728.00M → NLSPW

NLSPW vs EQR: Complete Analysis 2026

NLSPW — Stock

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.

Full NLSPW Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this NLSPW vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NLSPW vs SCHD NLSPW vs JEPI NLSPW vs O NLSPW vs KO NLSPW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.